CNBC's David Faber reports Valeant Pharmaceuticals is willing to increase its bid for Allergan to at least $200 a share. Jim Cramer provides insight to litigation against investor Bill Ackman over insider trading» Read More
A month after bolting from court barefoot, New York investor relations executive Michael Lucarelli pleads guilty on his 52nd birthday.
Banned ImClone founder Sam Waksal's new biotech company, Kadmon, has plans to go public. The company aims to file with the SEC by the end of this year.
Dmitry Braverman is the second employee of the Wilson Sonsini law firm to be accused of insider trading in recent years.
A federal insider trading investigation is broadening to include several hedge funds in light of new evidence, the WSJ reported.
In one of the longest prison sentences for insider trading, SAC's Martoma was also ordered to forfeit $9.38 million by a federal judge in New York.
CNBC's Kate Kelly reports the latest sentencing details for former SAC trader Mathew Martoma.
CNBC's Kate Kelly reports on former SAC portfolio manager Mathew Martoma's sentence day.
A federal judge is set to deliver what could be the harshest sentence for insider trading to date.
A man accused of insider trading bolted when he spotted cameras outside the courthouse. He continued to run even after his sandals slipped off.
FBI agents arrested Investors Relations executive Michael Lucarelli on charges related to insider trading. CNBC's Sue Herera shows video of Lucarelli taking off from CNBC cameras upon leaving the federal court building Tuesday.
A former Microsoft employee was sentenced to two years in prison for his part in an insider trading scheme that netted more than $400,000.
A lawsuit by Allergan says the unusual arrangement by Valeant Pharmaceuticals and activist investor Bill Ackman amounts to insider trading.
Allergan is suing Valeant, Bill Ackman and his firm Pershing Square for allegedly violating insider trading laws. Marc LoPresti of LoPresti Law Group, and CNBC's Robert Frank dissect the lawsuit.
CNBC's David Faber reports Allergan has filed a lawsuit against Valeant Pharmaceuticals and Pershing Square's Bill Ackman alleging a violation of federal securities laws.
The SEC is expanding an insider trading investigation which may have started with congressional staffers. CNBC's Eamon Javers reports the details.
Icahn Enterprises chairman Carl Icahn discusses the insider trading investigation with CNBC's Scott Wapner.
U.S. Attorney SDNY Preet Bharara, says he doesn't think any institution is inherently corrupt, but corrupt cultures develop in some areas.
U.S. Attorney SDNY Preet Bharara, discusses the objective of the BNP Paribas criminal case.
U.S. Attorney SDNY Preet Bharara, provides insight to some of the most recent insider trading cases, and why some people are still committing this crime.
Cohen proved to be a stickler for the letter of the law when it came to paying the criminal penalty imposed on his former hedge fund. The NYT reports.